LDE225 Diphosphate Catalog No.:M9943-10 Gene expression studies performed on

Gene expression studies performed on tibialis samples revealed that both GLPG0492 was slowing down muscle loss by negatively interfering with major signaling pathways controlling muscle mass homeostasis

CAS Number: 1019206-88-2

3D Matrigel Transwell invasion assays demonstrate that 10 μM HTH-01-015 markedly inhibits the invasiveness of U2OS cells in this assay

Bumbacea RS

Smiles: CC(=O)C1=CC=C(OCCCOC2C=CC(=CC=2)OCC(O)=O)C(CCC)=C1O

LDE225 Diphosphate Catalog No.:M9943-10 Gene expression studies performed onSonidegib, also known as, erismodegib, LDE225, NVP LDE225, is an orally bioavailable small molecule Smoothened (Smo) antagonist with potential antineoplastic activity. Erismodegib selectively binds to the Hedgehog (Hh) ligand cell surface receptor Smo, which may result in the suppression of the Hh signaling pathway and, so, the inhibition of tumor cells in which this pathway is abnormally activated. It was approved by the FDA for treating basal cell